Doctor of Podiatric Medicine Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Adam Perler

Podiatrist Largo, FL Doctor of Podiatric Medicine

NPI 1063507176 CMS profile 320994

12416 66Th Street N, Suite A, Largo, FL 33773

Open in the dashboard

General payments

$160,147

310 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Adam Perler of Largo, FL is reported in the CMS Open Payments database as having received $160,147 across 310 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Podiatrist profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $29,529 25
2024 General $28,750 34
2023 General $31,334 32
2022 General $19,773 49
2021 General $16,770 53
2020 General $1,739 21
2019 General $32,252 96

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Adam Perler
  • Podiatrist median
  • Middle half of Podiatrist
  • National median

In program year 2025, general payments to Adam Perler were reported at $29,529. Among 4,572 Podiatrist profiles paid that year, the median was $260 and the middle half received between $94 and $777.

Show as a table
Year Adam Perler Podiatrist median Middle half National median
2019 $32,252 $196 $72–$601 $163
2020 $1,739 $118 $38–$335 $114
2021 $16,770 $169 $57–$573 $132
2022 $19,773 $220 $74–$782 $149
2023 $31,334 $208 $71–$635 $160
2024 $28,750 $237 $87–$681 $164
2025 $29,529 $260 $94–$777 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. TriMed, Inc. $56,746 63 payments
  2. Treace Medical Concepts, Inc. $40,579 35 payments
  3. Linvatec Corporation $26,612 12 payments
  4. In2Bones USA, LLC $11,403 8 payments
  5. Zimmer Biomet Holdings, Inc. $10,399 23 payments
  6. Crossroads Extremity Systems, LLC $7,177 16 payments
  7. Stryker Corporation $2,583 43 payments
  8. Paragon 28, Inc. $747 6 payments
  9. Smith+Nephew, Inc. $732 11 payments
  10. Integra LifeSciences Corporation $429 14 payments
  11. Other $2,742 79 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $67,311 33 payments
  2. Royalty or License $51,404 29 payments
  3. Travel and Lodging $15,820 44 payments
  4. Food and Beverage $11,833 197 payments
  5. Honoraria $6,000 2 payments
  6. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $4,000 1 payment
  7. Compensation for serving as faculty or as a speaker for a medical education program $3,500 1 payment
  8. Entertainment $280 3 payments
Products named General payments · program years 2019–2025
  1. LAPIPLASTY SYSTEM $31,718 23 payments
  2. HERCULES SUTURE ANCHOR SYSTEM In2bones $13,301 4 payments
  3. Hercules $11,084 7 payments
  4. Rebalance Ankle $8,905 6 payments
  5. HERCULES SUTURE ANCHOR SYSTEM In2bones $8,084 4 payments
  6. Medical Implant $7,177 16 payments
  7. Tools - AFS $5,876 8 payments
  8. Tools - FPS $5,220 4 payments
  9. ANCHOR $5,209 3 payments
  10. LAPIPLASTY SYSTEM 1 $5,055 4 payments
  11. Other $17,626 231 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 8 drugs

Part D claims

196

Median for Podiatry: 160

Drug cost

$1,747

Median for Podiatry: $2,368

Branded share of claims

0%

Median for Podiatry: 12.7%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Gabapentin Generic 43 $550
Methylprednisolone Generic 43 $343
Celecoxib Generic 18 $235
Promethazine Hcl Generic 21 $139
Oxycodone Hcl Generic 20 $129
Cyclobenzaprine Hcl Generic 15 $127
Doxycycline Monohydrate Generic 13 $115
Meloxicam Generic 23 $109

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 14,093 Part D prescribers listed as Podiatry; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 45 billing codes

Paid by Medicare

$29,492

Of which drugs: $33

Medicare patients

103

Average age 73

Services billed

393

69 women, 34 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 68%
Chronic kidney disease 28%
Ischemic heart disease 24%
Osteoporosis 23%
Diabetes 21%
Depression 20%
Atrial fibrillation 19%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 13 47 $33

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

310 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Podiatrist in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record